Neurooncology clinical trial design for targeted therapies: Lessons learned from the North American Brain Tumor Consortium

The North American Brain Tumor Consortium (NABTC) is a multi-institutional consortium with the primary objective of evaluating novel therapeutic strategies through early phase clinical trials. The NABTC has made substantial changes to the design and methodology of its trials since its inception in 1...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chang, Susan M., Lamborn, Kathleen R., Kuhn, John G., Yung, W.K. Alfred, Gilbert, Mark R., Wen, Patrick Y., Fine, Howard A., Mehta, Minesh P., DeAngelis, Lisa M., Lieberman, Frank S., Cloughesy, Timothy F., Robins, H. Ian, Abrey, Lauren E., Prados, Michael D.
Format: Artigo
Langue:Inglês
Publié: Duke University Press 2008
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2666238/
https://ncbi.nlm.nih.gov/pubmed/18559968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2008-021
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires